New synthetic route for the enantioselective total synthesis of salinosporamide A and biologically active analogues

Organic Letters

Volumn 7, Issue 13, 2005, Pages 2699-2701

  Reddy, Leleti Rajender ^a   Fournier, Jean François ^a   Subba Reddy, B V ^a   Corey, E J ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LACTACYSTIN BETA LACTONE; LACTONE; PYRROLE DERIVATIVE; SALINOSPORAMIDE A;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CYCLIZATION; STEREOISOMERISM; SYNTHESIS;

CATALYSIS; CYCLIZATION; LACTONES; MOLECULAR STRUCTURE; PYRROLES; STEREOISOMERISM;

EID: 23044508316     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0508734     Document Type: Article

References (27)

1. Feling, R. H.; Buchanan, G. O.; Mincer, T. J.; Kauffman, C. A.; Jensen, P. R.; Fenical, W. Angew. Chem., Int. Ed. 2003, 42, 355-357.
2. (a) Reviewed in: Corey, E. J.; Li, W.-D. Z. Chem. Pharm. Bull. 1999, 47, 1-10.
3. (b) Corey, E. J.; Reichard, G. A.; Kania, R. Tetrahedron Lett. 1993, 34, 6977-6980.
4. (c) Corey, E. J.; Reichard, G. A. J. Am. Chem. Soc. 1992, 114, 10677-10678.
5. (d) Fenteany, G.; Standaert, R. F.; Reichard, G. A.; Corey, E. J.; Schreiber, S. L. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3358-3362.
6. (a) Omura, S.; Fujimoto, T.; Otoguro, K.; Matsuzaki, K.; Moriguchi, R.; Tanaka, H.; Sasaki, Y. J. Antibiot. 1991, 44, 113-116.
7. (b) Omura, S.; Matsuzaki, K.; Fujimoto, T.; Kosuge, K.; Furuya, T.; Fujita, S.; Nakagawa, A. J. Antibiot. 1991, 44, 117-118.
8. Bortezomib (Velcade), a peptidyl boronic acid which is a reversible (0.6 nM Ki) proteasome inhibitor, is currently in use and approved for the treatment of multiple myeloma. In addition, there are numerous ongoing clinical trials on the use of this agent for treatment of other malignant diseases. See: (a) Richardson, P. G.; Barlogie, B.; Berenson, J.; Singhal, S.; Jagannath, S.; Irwin, D.; Rajkumar, S. V.; Srkalovic, G.; Alsina, M.; Alexanian, R.; Siegel, D.; Orlowski, R. Z.; Kuter, D.; Limentani, S. A.; Lee, S.; Hideshima, T.; Esseltine, D.-L.; Kauffman, M.; Adams, J.; Schenkein, D. P.; Anderson, K. C. N. Engl. J. Med. 2003, 348, 2609-2617.
9. (b) Richardson, P. G.; Hideshima, T.; Anderson, K. C. Cancer Control 2003, 10, 361-369.
10. (c) Steinberg, D. The Scientist 2003, 17 (S2), S18-822.
11. (d) Adams, J. Proteasome Inhibitors in Cancer Therapy; Humana Press: New York, 2004.
12. Reddy, L. R.; Saravanan, P.; Corey, E. J. J. Am. Chem. Soc. 2004, 126, 6230-6231.
13. For reviews on the application of titanacyclopropane reagents, see (a) Kulinkovich, O. G. Chem. Rev. 2003, 103, 2597-2632.
14. (b) Sato, F.; Okamoto, S. Adv. Synth. Catal. 2001, 343, 759-784.
15. For the closest precedent to this cyclization involving δ,ε-enones, see: (a) Kablaoui, N. M.; Buchwald, S. L. J. Am. Chem. Soc. 1996, 118, 3182-3191.
16. (b) Mandal, S. K.; Amin, S. R.; Crowe, W. E. J. Am. Chem. Soc. 2001, 123, 6457-6458.
17. (c) Crowe, W. E.; Vu, A. T. J. Am. Chem. Soc. 1996, 118, 1557-1558.
18. (d) Quan, L. G.; Cha, J. K. Tetrahedron Lett. 2001, 42, 8567-8569.
19. 3SiCl is slow relative to that with the aldehyde 8. The inclusion of TMSCl in the reaction mixture allows rapid silylation of the alkoxide intermediate formed by attack of the Grignard reagent on 8, thereby preventing retroaldol cleavage of this adduct. See: Corey, E. J.; Li. W.; Nagamitsu, T. Angew. Chem., Int. Ed. 1998, 37, 1676-1679.
20. For reviews, see: (a) Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 3rd ed.; John Wiley and Sons: New York, 1999.
21. (b) Kocienski, P. J. Protecting Groups, 3rd ed.; Georg Thieme: Stuttgart, New York, 2004.
22. (c) Salomon, C. J.; Mata, E. G.; Mascaretti, O. A. Tetrahedron 1993, 49, 3691-3734.
23. (d) Nicolaou, K. C.; Estrada, A. A.; Zak, M.; Lee, S. H.; Safina, B. S. Angew. Chem., Int. Ed. 2005, 44, 1378-1382.
24. (e) Olah, G. A.; Narang, S. C.; Salem, G. F.; Gupta, B. G. B. Synthesis 1981, 142-143.
25. (f) Marchand, P. S. J. Chem. Soc., Chem. Commun. 1971, 667-668.
26. (g) Bartlett, P. A.; Johnson, W. S. Tetrahedron Lett. 1970, 4459-4462.
27. +: 276.1002; found: 276.1006. The β-lactone 3 prepared by the route shown in Scheme 1 was identical with a sample of 3 that had been synthesized in these laboratories by a different route (submitted for publication).